BSE - No shares traded
High
442.55
Low
441.50
6369.60 
22.50 (0.35%)
22.50 (0.35%)Ranbaxy Laboratories
LIVE
BSE
Feb 13, 17:00
438.80
-4.50 (-1.02%)
VOLUME 
63,572
63,572
AVERAGE VOLUME
| 5-Day | 65,346 |
| 10-Day | 97,173 |
| 30-Day | 95,449 |
VOLUME SHOCKER
| 5-Day | 65,346 |
| 10-Day | 97,173 |
| 30-Day | 95,449 |
Prev. Close
443.30
Open Price
444.10
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
438.80 (37)
Today’s Low/High
437.55
447.50
52 Wk Low/High
366.50
570.00
LIVE
NSE
Feb 13, 17:00
438.75
-3.65 (-0.83%)
VOLUME 480,182
480,182
AVERAGE VOLUME
| 5-Day | 503,325 |
| 10-Day | 666,552 |
| 30-Day | 815,771 |
VOLUME SHOCKER
| 5-Day | 503,325 |
| 10-Day | 666,552 |
| 30-Day | 815,771 |
Prev. Close
442.40
Open Price
442.40
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
438.75 (445)
Today’s Low/High
437.00
447.65
52 Wk Low/High
365.50
570.00
MARKET CAP (Rs Cr)
18,518.75
*BOOK VALUE (Rs)
121.47
Market Lot
1
*EPS (TTM)
-
*PRICE/BOOK
3.61
FACE VALUE (Rs)
5.00
*P/E
-
DIV (%)
40.00%
INDUSTRY P/E
10.62
*P/C
-
DIV YIELD.(%)
0.46%
EXPAND ALL
COLLAPSE ALLF&O Quote
Historic Prices & Simple Moving Averages
Simple Moving Averages
| Days | BSE | NSE |
| 30 | 427.32 | 427.44 |
| 50 | 432.17 | 432.26 |
| 150 | 483.78 | 483.99 |
| 200 | 485.40 | 485.63 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Ranbaxy Labs
The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
News/Videos & Announcements
News
Announcements
Jan 31, 2012
Ranbaxy Labs - FY11 results on Feb 23, 2012
Jan 27, 2012
Ranbaxy Labs - Ranbaxy Announces Court filing of Consent Decree with U.S. Food and Drug Administration 
Jan 13, 2012
Ranbaxy Labs - Allotment of Equity Shares
Videos
Jan 31, 2012
Stock Advice & Research Reports
Stock Advice
Research Reports
News/Videos Across the Web
Financials
Income Statement
(In Rs Cr)
| (Sep '11) Quarterly |
(Dec '10) Yearly |
|
| Net Sales | 1425.06 | 5672.10 |
| Other Income | 104.20 | 360.33 |
| PBDIT | 33.50 | 1593.21 |
| Net Profit | -439.20 | 1148.73 |
Balance Sheet
(Dec '10)
(In Rs Cr)
(In Rs Cr)
| Total Share Capital | 210.52 |
| Net Worth | 5132.40 |
| Total Debt | 4260.72 |
| Net Block | 1712.11 |
| Investments | 3804.44 |
| Net Current Assets | 3546.38 |
| Total Assets | 9393.11 |
Peers
Peer Comparison
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 552.55 | 2.08 | 565.75 | 404.00 | 57,221.08 |
| Dr Reddys Labs | 1626.05 | 0.38 | 1716.00 | 1387.00 | 27,568.71 |
| Cipla | 342.45 | -1.88 | 359.00 | 273.60 | 27,496.04 |
| Lupin | 462.95 | 0.90 | 492.00 | 363.00 | 20,676.37 |
| Ranbaxy Labs | 438.80 | -1.02 | 570.00 | 366.50 | 18,518.75 |
| More » | |||||
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
| Dec' 11 | Sep' 11 | Jun' 11 | Mar' 11 | |
| Promoter | 63.68 | 63.75 | 63.77 | 63.79 |
| FII | 8.47 | 8.86 | 8.79 | 7.51 |
| DII | 11.49 | 11.65 | 11.92 | 12.03 |
| Others | 16.36 | 15.74 | 15.52 | 16.67 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
Mutual Funds Holding
| Scheme | No. of Shares |
| Reliance Growth Fund - Retail Plan (G) | 3,624,772 |
| Reliance Equity Opportunities Fund - Retail Plan (G) | 1,982,889 |
| Reliance Vision Fund - Retail Plan (G) | 1,336,875 |
| Reliance Pharma Fund (G) | 1,261,044 |
Company Information
REGISTERED OFFICE
Address
A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar
District
Mohali
State
Punjab
Pin Code
160071
Tel. No.
0172-5013655
Fax No.
0172-5013376
Email:
Internet
REGISTRARS
Name
Alankit Assignment Ltd.
Address
2E/8, Blazeflash House, R T A Division, 1st Floor Jhandewalan Extension,
Tel. No.
011-51540060, 51540061, 51540062, 51540063
Fax No.
011-51540064
Email:
MANAGEMENT
Name
Designation
Tsutomu Une
Chairman / Chair Person
Arun Sawhney
Managing Director
Takashi Shoda
Director
Anthony H Wild
Director
Akihiro Watanabe
Director
Message Board & Community
Quick Links for Ranbaxy Laboratories
|
Related Searches
Ranbaxy Laboratories Stock Price, Ranbaxy Labs Stock Quote, Ranbaxy Labs Results , Ranbaxy Labs News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Motherson Sumi | Iran | Suzlon Energy | Reliance Power | Singapore Telecommunications | Sun Pharma | BSE Sensex | Tamil Nadu | Coal India IPO | State Bank of India
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Motherson Sumi | Iran | Suzlon Energy | Reliance Power | Singapore Telecommunications | Sun Pharma | BSE Sensex | Tamil Nadu | Coal India IPO | State Bank of India
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.